Departed
James Holm
Chief Financial Officer
CRON ·
Cronos Group Inc.
As of the Effective Date, James Holm will no longer serve as the Company’s Chief Financial Officer.
Ready 8-Ks
50
Latest filing
August 7, 2026, 5:03 PM ET
Top materiality
0.90
Event mix
earnings ×21 · other_material ×11 · leadership ×11
Sentiment
15 pos · 12 neg · 23 neu
Latest earnings
reported 2026-Q2
Executive change
recent →
Recent 8-K filings for CRON
Highest-materiality recent filing
Cronos to restate Q2 2021 financials; at least $220M impairment in U.S. reporting unit
- Previously issued unaudited interim financial statements for Q2 2021 should no longer be relied upon.
- Impairment charge of not less than $220M on goodwill and indefinite-lived intangible assets in U.S. reporting unit.
-
Cronos Group board adopts annual Say-on-Pay votes after shareholder preference
At June 18, 2026 annual meeting, shareholders preferred annual Say-on-Pay votes.
-
Cronos Q2 net revenue up 58% YoY to $53M; record Adjusted EBITDA of $13.1M
Net revenue $53.0M (+58% YoY); organic constant-currency growth 51%.
-
Cronos shareholders elect all 7 director nominees, approve say-on-pay at annual meeting
All 7 director nominees elected with >207M votes for each; Michael Gorenstein received 207.8M for, 14M withheld.
-
Net revenue $45.2M (+40% YoY); net income $15.7M (+103%); adjusted EBITDA $5.1M (+122%).
-
Cronos Group Q4 2025 net revenue $44.5M (+47% YoY); net loss $0.5M vs income $43.9M
Q4 net revenue $44.5M, up 47% YoY; full-year net revenue $146.6M, up 25% YoY.
-
Cronos to acquire CanAdelaar, Dutch cannabis market leader, for US$67M upfront plus earnouts
Upfront consideration of €57.5M (US$67.0M) cash, plus earnout of 0.5x normalized EBITDA in 2026 and 2027.
-
Cronos Group Q3 net revenue $36.3M (+6% YoY); record Adj. EBITDA of $5.7M
Net revenue $36.3M, up 6% YoY; gross profit $18.3M (50% margin) vs $3.6M (11%) a year ago.
-
Cronos terminates VP Controller Lloyd Wilson for cause effective Aug 29, 2025
Lloyd Wilson terminated as VP, Controller and Principal Accounting Officer for cause, effective immediately.
-
Cronos Q2 net revenue $33.5M (+21% YoY); adjusted EBITDA turns positive to $1.7M
Net revenue $33.5M, up 21% YoY; adjusted gross margin improved to 43% from 23%.
-
Cronos Group 2025 annual meeting: all director nominees elected, say-on-pay and auditor ratified
Seven director nominees elected with over 206M votes for each; broker non-votes ~53.8M.
-
Cronos Q1 net revenue $32.3M (+28% YoY), net income $7.7M; authorizes $50M buyback
Net revenue $32.3M (+28% YoY); net income $7.7M vs loss of $2.5M in Q1 2024.
-
Cronos Group appoints Anna Shlimak as CFO; James Holm departs
Anna Shlimak appointed CFO effective March 19, 2025; James Holm ceases as CFO but remains employed through April 18, 2025.
-
Cronos Group Q4 revenue up 27% YoY to $30.3M; reports net income of $43.9M vs prior year loss
Q4 net revenue $30.3M (+27% YoY); full-year revenue $117.6M (+35% YoY).
-
Cronos Group Q3 revenue up 38% to $34.3M; Spinach becomes #1 cannabis brand in Canada
Net revenue $34.3M, +38% YoY; net income $7.3M vs loss of $1.6M in Q3 2023.
-
Cronos Group Q2 net revenue rises 46% to $27.8M; net loss widens, Adj EBITDA improves
Net revenue $27.8M, up 46% YoY; gross profit $6.3M (+103%).
-
Cronos Group shareholders approve reappointment of Davidson & Company LLP as auditor
On July 19, 2024, reconvened annual meeting approved auditor appointment.
-
Cronos ups GrowCo credit by C$70M to C$175M, secures supply rights for Phase 2
Credit Agreement adds C$70M Term Loan B for Phase 2 cannabis facility; total facility now C$175M.
-
All six director nominees elected; Michael Gorenstein received 204.4M votes for, 14.4M against.
-
Cronos terminates sale-leaseback of Peace Naturals Campus after buyer fails condition
Agreement terminated May 28, 2024; Future Farmco Canada did not satisfy due diligence/financing condition by May 27 deadline.
-
Cronos Q1 revenue up 30% YoY to $25.3M; net loss narrows; guidance reaffirmed
Net revenue $25.3M (+30% YoY); gross profit $4.5M (+53%); net loss improved to $(2.5M) from $(18.0M).
-
Cronos enters voting agreement with Altria for 2024 annual meeting support
Altria agrees to vote its Cronos shares in favor of all company proposals at 2024 annual meeting.
-
Cronos Group auditor KPMG exits; will not seek re-appointment for 2024 audit
KPMG notified Cronos it will not stand for re-appointment for 2024 audit due to KPMG's decision to cease auditing cannabis companies.
-
Cronos Group appoints Adam Wagner as Head of Cronos Israel; Gorelik becomes Chairman
Ran Gorelik steps down as GM of Cronos Israel effective April 2, 2024; becomes Chairman through April 1, 2026.
-
Cronos Group Q4 net revenue up 9% YoY; net loss improves to $45M; cash balance $862M
Q4 net revenue $23.9M (+9% YoY); full-year net revenue $87.2M (+1% YoY).
-
Cronos Group enters sale-leaseback of Stayner facility for C$23M cash
Cronos subsidiary agrees to sell Peace Naturals Campus to Future Farmco Canada for C$23M.
-
Cronos Q3 net revenue $24.8M (+22% YoY); net loss narrows to $1.6M from $33.1M
Net revenue $24.8M (+22% YoY); constant currency $26.0M (+27% YoY). Grows driven by Canadian flower, extract sales.
-
Cronos Group Q2 revenue down 12% to $19M, withdraws FY2023 guidance; announces facility wind-down
Q2 net revenue $19.0M (-12% YoY); net loss improved to $(5.7)M from $(17.5)M YoY.
-
Cronos Group shareholders elect all seven directors, approve say-on-pay and auditor
Each director nominee elected with >94.8% support; Kamran Khan lowest at 94.81%.
-
Cronos Group to exit U.S. hemp CBD ops, raise savings target to $20-25M
Will wind down U.S. hemp-derived CBD operations by end of Q2 2023; expects up to $1.8M in exit costs.
-
Cronos Group appoints James McGinness as VP, Controller and principal accounting officer
James McGinness appointed VP, Controller and principal accounting officer effective May 22, 2023.
-
Cronos Q1 revenue $20.1M (-20% YoY); gross margin 12%; targets cash flow positive 2024
Net revenue $20.1M, down 20% YoY; gross margin 12% vs 28%; net loss $(19.3)M improved from $(32.7)M.
-
Full-year 2022 net revenue $91.9M, up 23% YoY; Israel revenue up 128% (constant currency +137%).
-
Lump sum payment of $450,000 (one year salary) plus $18,356.61 for benefits premium.
-
Altria relinquishes warrant to buy 84.2M Cronos shares at C$19 for no consideration
Altria abandoned warrant for up to 84,243,223 Cronos common shares at C$19.00 per share, effective Dec 16, 2022, for no consideration.
-
Cronos Group names James Holm as CFO effective Nov 14, 2022; Robert Madore departs
Robert Madore ceased as CFO; receives one-year base salary severance, pro-rated bonus, and accelerated vesting of 37,500 RSUs and 450,000 options.
-
Cronos Q3 revenue up 3% to $20.9M; net loss $36.9M vs prior year income; Jeff Jacobson named CGO
Consolidated net revenue $20.9M, up 3% YoY; constant currency +7% to $21.8M.
-
Cronos settles SEC and OSC investigations over accounting errors; pays C$1.34M, loses WKSI status
SEC order imposes cease-and-desist; no monetary penalty but Cronos loses WKSI status for 3 years and Regulation A/D exemption use for 5 years.
-
Cronos Group SVP John Griese departs; Jeff Jacobson assumes North American operations
John Griese no longer serves as SVP, Head of Operations (North America) effective Oct 18, 2022.
-
Cronos Q2 net revenue $23.1M (+48% YoY); net loss narrows to $20.3M from $179.4M
Consolidated net revenue $23.1M, up 48% YoY; Rest of World segment $21.6M (+61%); U.S. $1.5M (-34%).
-
Cronos Group announces 2022 Annual Meeting results; all directors elected
All seven director nominees elected with >91.6% votes each; Jason Adler 92.14%, James Rudyk 91.63%.
-
Cronos Q1 revenue up 99% YoY to $25M; net loss narrows; Gorenstein returns as CEO
Consolidated net revenue $25.0M (+99% YoY); Israel net revenue $9.1M (+263% YoY).
-
Cronos Group founder Mike Gorenstein returns as CEO, replaces retiring Kurt Schmidt
Gorenstein appointed President and CEO effective March 21, 2022; continues as Chairman.
-
Cronos Group Q4 revenue $25.8M (+51% YoY), net loss $133.9M; plans Stayner facility exit
Net revenue $25.8M in Q4 (+51% YoY); full-year revenue $74.4M (+59% YoY).
-
Cronos restates Q2 2021 with $236M impairment; Q3 rev up 80% to $20.4M, adj EBITDA loss widens
Restated Q2 2021 with $236.1M impairment on goodwill and intangibles in U.S. reporting unit; no cash impact.
-
Cronos Group appoints John Griese as SVP, Head of Operations (North America)
John Griese promoted to SVP, Head of Operations (North America) effective Jan 10, 2022.
-
Cronos Group EVP & Corporate Secretary Xiuming Shum resigns effective Nov 30, 2021
Xiuming Shum resigns as EVP, Legal & Regulatory Affairs and Corporate Secretary effective Nov 30, 2021.
-
Cronos Group receives Nasdaq delinquency notice for late Q3 10-Q; MCTO issued
Nasdaq notice, dated Nov 16, 2021, cites non-compliance with Listing Rule 5250(c)(1) for untimely Form 10-Q.
-
Cronos to restate Q2 2021 financials; at least $220M impairment in U.S. reporting unit
Previously issued unaudited interim financial statements for Q2 2021 should no longer be relied upon.
-
Dr. Todd Abraham retires as Cronos Group Chief Innovation Officer
Dr. Todd Abraham retired as Chief Innovation Officer, effective October 29, 2021.
-
Net revenue $15.6M, up 58% YoY; ROW segment $13.4M (+74%) driven by Canada adult-use and Israel medical.
Executive changes
Appointed
Anna Shlimak
Chief Financial Officer
CRON ·
Cronos Group Inc.
Effective as of March 19, 2025 (the “Effective Date”), Cronos Group Inc. (the “Company”) has appointed Anna Shlimak, the Company’s Chief Strategy Officer, as the Company’s Chief Financial Officer.
Role change
Ran Gorelik
Chairman of Cronos Israel
CRON ·
Cronos Group Inc.
pursuant to which Mr. Gorelik will become Chairman of Cronos Israel and will no longer serve as General Manager (Cronos Israel).
Appointed
James McGinness
Vice President, Controller
CRON ·
Cronos Group Inc.
On May 18, 2023, Cronos Group Inc. (the “Company”) appointed James McGinness to the position of Vice President, Controller, which includes serving as the Company’s principal accounting officer, effective as of May 22, 2023.
Departed
Carlos Cortez
Vice President, Controller
CRON ·
Cronos Group Inc.
On May 18, 2023, the Company determined that Carlos Cortez, the Company’s Vice President, Controller, will no longer serve as the Company’s principal accounting officer as of May 22, 2023 and will separate from the Company, effective as of June 16, 2023.
Departed
Robert Madore
Chief Financial Officer
CRON ·
Cronos Group Inc.
As previously disclosed, effective as of November 14, 2022, Robert Madore ceased to serve as Chief Financial Officer of Cronos Group Inc.
Appointed
James Holm
Chief Financial Officer
CRON ·
Cronos Group Inc.
the Company has appointed James Holm as Chief Financial Officer of the Company.
Departed
Robert Madore
Chief Financial Officer
CRON ·
Cronos Group Inc.
Robert Madore will no longer serve as Chief Financial Officer of Cronos Group Inc.
Departed
John Griese
Senior Vice President, Head of Operations (North America)
CRON ·
Cronos Group Inc.
Effective as of the close of business on October 18, 2022, John Griese will no longer serve as Senior Vice President, Head of Operations (North America) of Cronos Group Inc.
Departed
Kurt Schmidt
President and Chief Executive Officer
CRON ·
Cronos Group Inc.
Kurt Schmidt retired from the positions of President and Chief Executive Officer of Cronos Group.
Appointed
Michael Gorenstein
President and Chief Executive Officer
CRON ·
Cronos Group Inc.
appointed Michael Gorenstein as President and Chief Executive Officer of Cronos Group, effective as of March 21, 2022
Appointed
John Griese
Senior Vice President, Head of Operations (North America)
CRON ·
Cronos Group Inc.
On January 10, 2022, Cronos Group Inc. (the “Company”) appointed John Griese as Senior Vice President, Head of Operations (North America) of the Company.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.90 · Median 0.65 · Most common event earnings